Updated:
IZI Medical Products
IZI Medical Products is a other based in Owings Mills, founded 1991; the Altss profile covers its classification, headquarters, registration, AUM band, and key...
IZI Medical Products
IZI Medical provides innovative medical devices and distribution solutions for superior patient care, efficiency, and positive clinical outcomes.
General information
Firm type
other
Year founded
1991
Location
Region
North America
Country
United States
City
Owings Mills
Corporate office
5 Easter Court, Suite J, Owings Mills, MD 21117, United States
Sector focus
Frequently asked questions
How does IZI Medical Products' ownership structure affect its strategy?
IZI operates as a standalone subsidiary of Halma plc, which provides long-term capital and strategic support without requiring a near-term exit. This ownership allows IZI to focus on product development and physician partnerships rather than quarterly earnings pressure. Halma's model emphasizes autonomous operations and decentralized decision-making (per Halma plc, 2025).
What geographic markets does IZI Medical Products serve?
IZI sells to more than 2,000 domestic customers in the United States and distributes products in 25 countries internationally. The company's headquarters is in Owings Mills, Maryland, and it does not disclose any additional office locations (per the firm's website, 2025).
What product areas does IZI Medical Products focus on?
IZI's portfolio includes soft tissue biopsy systems (Quick-Core Auto Biopsy Needle), breast localization products, vertebral augmentation systems (Blazer-C, Osteo-Site balloon), and bone cement for vertebroplasty and kyphoplasty (Vertefix MV). The company also has products for image-guided surgery and radiation therapy (per the firm's website, 2025).
Does IZI Medical Products disclose financial data?
IZI Medical Products does not publicly disclose its AUM, revenue, profitability, or number of employees. Financial data for the company is reported within Halma plc's consolidated filings, which are publicly available but not broken out for individual subsidiaries (Altss research).
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: